These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38548438)

  • 1. The Health Care Burden of Hepatic Encephalopathy.
    Harris KB; Gonzalez HC; Gordon SC
    Clin Liver Dis; 2024 May; 28(2):265-272. PubMed ID: 38548438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing Burden of Hepatic Encephalopathy Among Hospitalized Adults: An Analysis of the 2010-2014 National Inpatient Sample.
    Hirode G; Vittinghoff E; Wong RJ
    Dig Dis Sci; 2019 Jun; 64(6):1448-1457. PubMed ID: 30863953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing Readmissions for Hepatic Encephalopathy.
    Makhani SS; Lee S; Bernstein D
    Clin Liver Dis; 2024 May; 28(2):345-358. PubMed ID: 38548444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The burden of hepatic encephalopathy in Latin America.
    Dávalos Moscol M; Bustios Sanchez C
    Ann Hepatol; 2011 Jun; 10 Suppl 2():S31-5. PubMed ID: 22228878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of compensated and decompensated cirrhosis: real world data from an Italian population-based cohort study.
    Cammarota S; Citarella A; Bernardi FF; Claar E; Fogliasecca M; Manzo V; Rosato V; Toraldo B; Trama U; Valente A; Conti V
    Eur Rev Med Pharmacol Sci; 2021 Jul; 25(13):4490-4498. PubMed ID: 34286491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: the burden of hepatic encephalopathy.
    Poordad FF
    Aliment Pharmacol Ther; 2007 Feb; 25 Suppl 1():3-9. PubMed ID: 17295846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes after hepatic encephalopathy in population-based cohorts of patients with cirrhosis.
    Tapper EB; Aberasturi D; Zhao Z; Hsu CY; Parikh ND
    Aliment Pharmacol Ther; 2020 Jun; 51(12):1397-1405. PubMed ID: 32363684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nationwide estimates and risk factors of hospital readmission in patients with cirrhosis in the United States.
    Shaheen AA; Nguyen HH; Congly SE; Kaplan GG; Swain MG
    Liver Int; 2019 May; 39(5):878-884. PubMed ID: 30688401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic encephalopathy.
    Bleibel W; Al-Osaimi AM
    Saudi J Gastroenterol; 2012; 18(5):301-9. PubMed ID: 23006457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Social Impact of Hepatic Encephalopathy.
    Shetty A; Saab EG; Choi G
    Clin Liver Dis; 2024 May; 28(2):273-285. PubMed ID: 38548439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world clinical features, health-care utilization, and economic burden in decompensated cirrhosis patients: A national database.
    Lee H; Kim BK
    J Gastroenterol Hepatol; 2022 Nov; 37(11):2154-2163. PubMed ID: 35862281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population characteristics, healthcare pathways and outcomes of patients with cirrhosis hospitalized with overt hepatic encephalopathy in France: A study of the French Hospital-Discharge Database.
    Thabut D; Roux J; Sultanik P; Tamberou C; Prost PL; Hagège H
    Clin Res Hepatol Gastroenterol; 2024 Mar; 48(3):102274. PubMed ID: 38154597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic encephalopathy as a complication of liver cirrhosis: an Asian perspective.
    Moriwaki H; Shiraki M; Iwasa J; Terakura Y
    J Gastroenterol Hepatol; 2010 May; 25(5):858-63. PubMed ID: 20546438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic Encephalopathy and Nutrition Influences: A Narrative Review.
    Fallahzadeh MA; Rahimi RS
    Nutr Clin Pract; 2020 Feb; 35(1):36-48. PubMed ID: 31872484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate, reasons, predictors, and burden of readmissions after transjugular intrahepatic portosystemic shunt placement.
    Khan A; Maheshwari S; Gupta K; Naseem K; Chowdry M; Singh S
    J Gastroenterol Hepatol; 2021 Mar; 36(3):775-781. PubMed ID: 32710679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic Encephalopathy Challenges, Burden, and Diagnostic and Therapeutic Approach.
    Yanny B; Winters A; Boutros S; Saab S
    Clin Liver Dis; 2019 Nov; 23(4):607-623. PubMed ID: 31563214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic Encephalopathy: Current and Emerging Treatment Modalities.
    Fallahzadeh MA; Rahimi RS
    Clin Gastroenterol Hepatol; 2022 Aug; 20(8S):S9-S19. PubMed ID: 35940731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic Encephalopathy and Liver Transplantation: The Past, Present, and Future Toward Equitable Access.
    Acharya C; Bajaj JS
    Liver Transpl; 2021 Dec; 27(12):1830-1843. PubMed ID: 34018659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing Readmissions of Hepatic Encephalopathy: Strategies in the Acute Inpatient, Immediate Postdischarge, and Longitudinal Outpatient Setting.
    Lin E; Gandhi D; Volk M
    Clin Liver Dis; 2024 May; 28(2):359-367. PubMed ID: 38548445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of Hepatic Encephalopathy.
    Elsaid MI; Rustgi VK
    Clin Liver Dis; 2020 May; 24(2):157-174. PubMed ID: 32245524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.